Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FODKLINIKKEN - VIBORG ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   15.4% 11.3% 10.3% 13.5% 12.7% 14.3% 20.6% 20.4%   Credit score (0-100)   14 21 22 16 17 15 5 5   Credit rating   BB BB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   279 278 235 284 258 229 0.0 0.0   EBITDA   21.7 38.5 -31.8 37.9 -0.5 17.8 0.0 0.0   EBIT   21.7 38.5 -31.8 37.9 -0.5 17.8 0.0 0.0   Pre-tax profit (PTP)   21.7 37.1 -33.7 35.8 -2.1 16.3 0.0 0.0   Net earnings   16.9 28.8 -26.3 27.9 -1.6 12.7 0.0 0.0   Pre-tax profit without non-rec. items   21.7 37.1 -33.7 35.8 -2.1 16.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -1.8 27.1 0.8 28.7 27.1 39.8 -89.0 -89.0   Interest-bearing liabilities   37.4 22.8 17.5 36.7 19.2 16.8 89.0 89.0   Balance sheet total (assets)   84.7 150 104 125 82.4 71.8 0.0 0.0   Net Debt   13.2 -74.2 -39.4 -51.8 -27.4 -24.4 89.0 89.0     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   279 278 235 284 258 229 0.0 0.0   Gross profit growth   -1.5% -0.3% -15.6% 20.9% -9.0% -11.2% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   85 150 104 125 82 72 0 0   Balance sheet change%   6.9% 77.0% -30.5% 19.7% -33.9% -12.8% -100.0% 0.0%   Added value   21.7 38.5 -31.8 37.9 -0.5 17.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.8% 13.9% -13.5% 13.4% -0.2% 7.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   23.6% 32.6% -25.0% 33.2% -0.4% 23.3% 0.0% 0.0%   ROI %   52.1% 88.3% -93.3% 90.6% -0.8% 34.9% 0.0% 0.0%   ROE %   20.6% 51.6% -189.2% 189.8% -5.8% 38.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -2.0% 18.1% 0.7% 23.0% 32.8% 55.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   60.6% -192.6% 124.1% -136.7% 5,873.9% -136.6% 0.0% 0.0%   Gearing %   -2,127.9% 84.2% 2,320.4% 128.0% 71.1% 42.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 4.8% 9.7% 7.8% 5.8% 8.9% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.0 1.2 1.0 1.3 1.5 2.2 0.0 0.0   Current Ratio   1.0 1.2 1.0 1.3 1.5 2.2 0.0 0.0   Cash and cash equivalent   24.3 97.0 56.9 88.5 46.7 41.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1.8 27.1 0.8 28.7 27.1 39.8 -44.5 -44.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   22 39 -32 38 -0 18 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   22 39 -32 38 -0 18 0 0   EBIT / employee   22 39 -32 38 -0 18 0 0   Net earnings / employee   17 29 -26 28 -2 13 0 0